What is the appropriate empirical treatment for acute urethritis in a male patient?

Empirical Treatment for Male Urethritis

For acute male urethritis, initiate empirical treatment with doxycycline 100 mg orally twice daily for 7 days OR azithromycin 1 g orally as a single dose, targeting both Chlamydia trachomatis and Mycoplasma genitalium, while awaiting confirmatory testing results 1.

Diagnostic Confirmation Before Treatment

Before initiating therapy, confirm urethritis is present by documenting at least one of the following:

• Visible urethral discharge
• Positive leukocyte esterase test on first-void urine
• ≥10 white blood cells per high-power field on microscopic examination of first-void urine sediment 1

If none of these objective criteria are present, empirical treatment should only be given to high-risk patients unlikely to return for follow-up 1.

Treatment Selection Algorithm

First-Line Empirical Regimens (Choose One):

• Azithromycin 1 g orally single dose - preferred for M. genitalium coverage and compliance 1
• Doxycycline 100 mg orally twice daily for 7 days - equally effective for chlamydial urethritis 1

Important Nuance on Azithromycin:

While the 2010 CDC guidelines recommend azithromycin as first-line 1, more recent evidence from 2026 advises against using azithromycin as first-line treatment to prevent further resistance development in N. gonorrhoeae and M. genitalium 2. However, given the guideline hierarchy prioritization, the established CDC recommendations remain the standard, though clinicians should be aware of emerging resistance concerns.

Alternative Regimens (if first-line contraindicated):

• Erythromycin base 500 mg orally four times daily for 7 days
• Erythromycin ethylsuccinate 800 mg orally four times daily for 7 days
• Levofloxacin 500 mg orally once daily for 7 days
• Ofloxacin 300 mg orally twice daily for 7 days 1

Critical Management Points

Timing and Dispensing:

• Initiate treatment immediately upon diagnosis confirmation 1
• Dispense medications on-site when possible
• Directly observe the first dose to maximize compliance 1

Sexual Activity Restrictions:

• Abstain from sexual intercourse for 7 days after single-dose therapy or until completion of 7-day regimen AND symptom resolution 1
• Partners must also complete treatment before resuming sexual activity 1

Testing Requirements:

All patients with confirmed or suspected urethritis must be tested for both gonorrhea and chlamydia using nucleic acid amplification tests (NAATs), as clinical presentation alone cannot reliably distinguish between pathogens 1, 3.

Partner Management

All sexual partners within the preceding 60 days require evaluation, testing, and empiric treatment with a chlamydia-effective regimen, regardless of whether a specific etiology is identified 1. Expedited partner treatment (providing prescriptions without partner examination) is an acceptable alternative approach 1, 4.

Common Pitfalls to Avoid

1. Do not treat based on symptoms alone without objective evidence of urethral inflammation 1
2. Do not perform routine test-of-cure at 3-4 weeks unless symptoms persist, noncompliance suspected, or reinfection likely 1
3. Do perform repeat testing at 3-6 months due to high reinfection rates (regardless of partner treatment status) 1
4. Urethral discharge is an independent predictor of positive PCR results even with negative urinalysis 5, so maintain high suspicion in these patients

Persistent/Recurrent Urethritis Management

If symptoms persist after initial treatment:

• First assess compliance and reinfection risk
• If doxycycline was used initially: switch to azithromycin (5-day regimen) plus metronidazole 400-500 mg twice daily for 5-7 days
• If azithromycin was used initially: switch to doxycycline plus metronidazole, or moxifloxacin 400 mg once daily for 7-14 days 6
• Consider M. genitalium resistance or Trichomonas vaginalis as causes 1, 6